HESTER BIOSCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,400 INR | -2.61% |
|
-3.75% | +64.65% |
| 10/05 | Transcript : Hester Biosciences Limited, Q4 2024 Earnings Call, May 10, 2024 | |
| 10/05 | Hester Biosciences' Consolidated Net Profit Rises in Fiscal Q4; Shares Jump 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Veterinary Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 7.91TCr | ||||||
| 713.1Cr | - | |||||
| 357.99Cr | ||||||
| 292.8Cr | ||||||
| 169.31Cr |
